Estrogen receptor β variants modify risk for Alzheimer's disease in a multiethnic female cohort

Journal of Alzheimer's Disease

Volumn 40, Issue 1, 2014, Pages 83-93

  Janicki, Sarah C ^a,b   Park, Naeun ^a,b   Cheng, Rong ^a,b   Lee, Joseph H ^a,b,c   Schupf, Nicole ^a,b,c   Clark, Lorraine N ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b Vagelos College of Physicians and Surgeons   (United States)

^c Department of Medicine   (United States)

Author keywords

Alzheimer's disease; estrogen receptor 2; estrogen receptors beta; genetic association studies; Hispanic; women

Indexed keywords

APOLIPOPROTEIN E4; ESTROGEN RECEPTOR BETA;

AFRICAN AMERICAN; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CAUCASIAN; COMORBIDITY; EDUCATIONAL STATUS; ENVIRONMENTAL FACTOR; ETHNICITY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ALZHEIMER'S DISEASE; ESTROGEN RECEPTOR 2; ESTROGEN RECEPTORS BETA; GENETIC ASSOCIATION STUDIES; HISPANIC; WOMEN;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; COHORT STUDIES; ESTROGEN RECEPTOR BETA; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84901808403     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-130551     Document Type: Article

References (51)

1. Shughrue PJ, Lane MV, Merchenthaler I (1997) Comparative distribution ofestrogen receptor-alpha and-beta mRNA inthe rat central nervous system. J Comp Neurol 388, 507-525.
2. McEwen BS (2001) Invited review: Estrogens effects on the brain: Multiple sites and molecular mechanisms. J Appl Phys-iol 91, 2785-2801.
3. Wang JM, Liu L, Brinton RD (2008) Estradiol-17beta-induced human neural progenitor cell proliferation is mediated by an estrogen receptor beta-phosphorylated extra-cellularly regulated kinase pathway. Endocrinology 149, 208-218.
4. Goodman Y, Bruce AJ, Cheng B, Mattson MP (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hip-pocampal neurons. J Neurochem 66, 1836-1844.
5. Toran-Allerand CD, Miranda RC, Bentham WD, Sohrabji F, Brown TJ, Hochberg RB, MacLusky NJ (1992) Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci U S A 89, 4668-4672.
6. Luine VN (1985) Estradiol increases choline acetyltrans-ferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 89, 484-490.
7. Behl C, Widmann M, Trapp T, Holsboer F (1995) 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 216, 473-482.
8. Jaffe AB, Toran-Allerand CD, Greengard P, Gandy SE (1994) Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J Biol Chem 269, 13065-13068.
9. Zhao L, Yao J, Mao Z, Chen S, Wang Y, Brinton RD (2011) 17beta-Estradiol regulates insulin-degrading enzyme expression via an ERbeta/PI3-K pathway in hippocampus: Relevance to Alzheimer's prevention. Neurobiol Aging 32, 1949-1963.
10. Brinton RD (2008) The healthy cell bias of estrogen action: Mitochondrial bioenergetics and neurological implications. Trends Neurosci 31, 529-537.
11. Pike AC, Brzozowski AM, Walton J, Hubbard RE, Thorsell AG, Li YL, Gustafsson JA, Carlquist M (2001) Structural insights into the mode of action of a pure antiestrogen. Structure 9, 145-153.
12. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafs-son JA (2001) Mechanisms of estrogen action. Physiol Rev 81, 1535-1565.
13. Liu F, Day M, Muniz LC, Bitran D, Arias R, Revilla-Sanchez R, Grauer S, Zhang G, Kelley C, Pulito V, Sung A, Mervis RF, Navarra R, Hirst WD, Reinhart PH, Marquis KL, Moss SJ, Pangalos MN, Brandon NJ (2008) Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory. Nat Neurosci 11, 334-343.
14. Forsell C, Enmark E, Axelman K, Blomberg M, Wahlund LO, Gustafsson JA, Lannfelt L (2001) Investigations of a CA repeat in the oestrogen receptor beta gene in patients with Alzheimer's disease. Eur J Hum Genet 9, 802-804.
15. Luckhaus C, Spiegler C, Ibach B, Fischer P, Wichart I, Sterba N, Gatterer G, Rainer M, Jungwirth S, Huber K, Tragl KH, Grunblatt E, Riederer P, Sand PG (2006) Estrogen receptor beta gene (ESRbeta) 3'-UTR variants in Alzheimer disease. Alzheimer Dis Assoc Disord 20, 322-323.
16. Pirskanen M, Hiltunen M, Mannermaa A, Helisalmi S, Lehtovirta M, Hanninen T, Soininen H (2005) Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women. Eur J Hum Genet 13, 1000-1006.
17. Yaffe K, Lindquist K, Sen S, Cauley J, Ferrell R, Penninx B, Harris T, Li R, Cummings SR (2009) Estrogen receptor genotype and risk of cognitive impairment in elders: Findings from the Health ABC study. Neurobiol Aging 30, 607-614.
18. Lambert JC, Harris JM, Mann D, Lemmon H, Coates J, Cumming A, St-Clair D, Lendon C (2001) Are the estrogen receptors involved in Alzheimer's disease? Neurosci Lett 306, 193-197.
19. Tang MX, Cross P, Andrews H, Jacobs DM, Small S, Bell K, Merchant C, Lantigua R, Costa R, Stern Y, Mayeux R (2001) Incidenceof ADin African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 56, 49-56.
20. Stern Y, Andrews H, Pittman J, Sano M, Tatemichi T, Lantigua R, Mayeux R (1992) Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol 49, 453-460.
21. Pritchard JK, Stephens M, Donnelly P (2000) Inference of population structure using multilocus genotype data.Genetics 155, 945-959.
22. Falush D, Stephens M, Pritchard JK (2003) Inference of population structure using multilocus genotype data: Linked loci and correlated allele frequencies. Genetics 164, 1567-1587.
23. Lee JH, Cheng R, Barral S, Reitz C, Medrano M, Lantigua R, Jimenez-Velazquez IZ, Rogaeva E, St George-Hyslop PH, Mayeux R (2011) Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. Arch Neurol 68, 320-328.
24. Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG (1989) The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 129, 1120-1131.
25. Meldrum DR, Davidson BJ, Tataryn IV, Judd HL (1981) Changes in circulating steroids with aging in postmenopausal women. Obstet Gynecol 57, 624-628.
26. Judd HL, Shamonki IM, Frumar AM, Lagasse LD (1982) Origin of serum estradiol in postmenopausal women. Obstet Gynecol 59, 680-686.
27. Mayeux R, Stern Y, Ottman R, Tatemichi TK, Tang MX, Maestre G, Ngai C, Tycko B, Ginsberg H (1993) The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann Neurol 34, 752-754.
28. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31, 545-548.
29. Zhao Q, Lee JH, Pang D, Temkin A, Park N, Janicki SC, Zig-man WB, Silverman W, Tycko B, Schupf N (2011) Estrogen receptor-Beta variants are associated with increased risk of Alzheimer's disease in women with down syndrome. Dement Geriatr Cogn Disord 32, 241-249.
30. Fitzpatrick JL, Mize AL, Wade CB, Harris JA, Shapiro RA, Dorsa DM (2002) Estrogen-mediated neuroprotection against beta-amyloid toxicity requires expression of estrogen receptor alpha or beta and activation of the MAPK pathway. J Neurochem 82, 674-682.
31. Mize AL, Shapiro RA, Dorsa DM (2003) Estrogen receptor-mediated neuroprotection from oxidative stress requires activation of the mitogen-activated protein kinase pathway. Endocrinology 144, 306-312.
32. Zhao L, Wu TW, Brinton RD (2004) Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res 1010, 22-34.
33. Baker AE, Brautigam VM, Watters JJ (2004) Estrogen modulates microglial inflammatory mediator production via interactions with estrogen receptor beta. Endocrinology 145, 5021-5032.
34. Wang L, Andersson S, Warner M, Gustafsson JA (2001) Morphological abnormalities in the brains of estrogen receptor beta knockout mice. Proc Natl Acad Sci U S A 98, 2792-2796.
35. Osterlund MK, Gustafsson JA, Keller E, Hurd YL (2000) Estrogen receptor beta (ERbeta) messenger ribonucleic acid (mRNA) expression within the human forebrain: Distinct distribution pattern to ERalpha mRNA. J Clin Endocrinol Metab 85, 3840-3846.
36. Savaskan E, Olivieri G, Meier F, Ravid R, Muller-Spahn F (2001) Hippocampal estrogen beta-receptor immunoreac-tivity is increased in Alzheimer's disease. Brain Res 908, 113-119.
37. Silva RC, Costa IR, Bordin BM, Silva CT, Souza SR, Junior CL, Frare AB, Moura KK (2011) RsaI polymorphism of the ERbeta gene in women with endometriosis. Genet Mol Res 10, 465-470.
38. Bianco B, Christofolini DM, Mafra FA, Brandes A, Zulli K, Barbosa CP (2009) +1730 G/A polymorphism of the estrogen receptor beta gene (ERbeta) may be an important genetic factor predisposingtoendometriosis.Acta Obstet Gynecol Scand 88, 1397-1401.
39. Geng L, Yao Z, Yang H, Luo J, Han L, Lu Q (2007) Association of CA repeat polymorphism in estrogen receptor beta gene with postmenopausal osteoporosis in Chinese. J Genet Genomics 34, 868-876.
40. Lau HH, Ho AY, Luk KD, Kung AW (2002) Estrogenreceptor beta gene polymorphisms are associated with higher bone mineral density in premenopausal, but not postmenopausal southern Chinese women. Bone 31, 276-281.
41. Ogawa S, Emi M, Shiraki M, Hosoi T, Ouchi Y, Inoue S (2000) Association of estrogen receptor beta (ESR2) gene polymorphism with bloodpressure.JHum Genet45, 327-330.
42. Scariano JK, Simplicio SG, Montoya GD, Garry PJ, Baum-gartner RN (2004) Estrogen receptor beta dinucleotide (CA) repeat polymorphism is significantly associated with bone mineral density in postmenopausal women. Calcif Tissue Int 74, 501-508.
43. Shearman AM, Karasik D, Gruenthal KM, Demissie S, Cup-ples LA, Housman DE, Kiel DP (2004) Estrogen receptor beta polymorphisms are associated with bone mass in women and men: The Framingham Study. J Bone Miner Res 19, 773-781.
44. Treeck O, Elemenler E, Kriener C, Horn F, Springwald A, Hartmann A, Ortmann O (2009) Polymorphisms in the promoter region of ESR2 gene and breast cancer susceptibility. J Steroid Biochem Mol Biol 114, 207-211.
45. Lurie G, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME, Terada KY, Goodman MT (2009) Genetic polymorphisms in the estrogen receptor beta (ESR2) gene and the risk of epithelial ovarian carcinoma. Cancer Causes Control 20, 47-55.
46. Xin JW, Zhang JJ, Yang Y, Gao YZ, Xiong L (2013) [Association of estrogen receptor beta gene polymorphisms with hypertension in postmenopausal women]. Zhonghua Yi Xue Za Zhi 93, 1657-1659.
47. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D, Hodgin J, Shaul PW, Thoren P, Smithies O, Gustafsson JA, Mendelsohn ME (2002) Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 295, 505-508.
48. Goulart AC, Zee RY, Pradhan A, Rexrode KM (2009) Associations of the estrogen receptors 1 and 2 gene polymorphisms with the metabolic syndrome in women. Metab Syndr Relat Disord 7, 111-117.
49. Goulart AC, Zee RY, Rexrode KM (2009) Association of estrogen receptor 2 gene polymorphisms with obesity in women (obesity and estrogen receptor 2 gene). Maturitas 62, 179-183.
50. Smiderle L, Mattevi VS, Giovenardi M, Wender MC, Hutz MH, Almeida S (2012) Are polymorphisms in oestrogen receptors genes associated with lipid levels in response to hormone therapy? Gynecol Endocrinol 28, 644-648.
51. Saltiki K, Mantzou E, Doukas C, Kanakakis I, Zotos P, Lazaros L, Georgiou I, Alevizaki M (2009) Estrogen receptor beta gene variants may be associated with more favorable metabolic profile in postmenopausal women undergoing coronary angiography. Exp Clin Endocrinol Diabetes 117, 610-615.